Who sells to Cardinal Health
9 listed companies name Cardinal Health as a customer behind 10% or more of their revenue, led by Pacira BioSciences at 26%.
Each share is of the supplier’s own revenue: how much of its business Cardinal Health is. Cardinal Health's own customers and margins
Suppliers that name Cardinal Health
Cardinal Health as a share of each supplier's revenue, largest first.
| Supplier | Of its revenue | Annual report |
|---|---|---|
| PCRXPacira BioSciences | 26% | FY2025 10-K |
| BMYBristol Myers Squibb | 22% | FY2025 10-K |
| ARDXArdelyx | 21% | FY2025 10-K |
| AMPHAmphastar Pharmaceuticals | 19% | FY2025 10-K |
| ALKSAlkermes | 17% | FY2025 10-K |
| BHCBausch Health Companies | 14% | FY2025 10-K |
| PFEPfizer | 13% | FY2025 10-K |
| MRNAModerna | 11% | FY2025 10-K |
| BLCOBausch + Lomb | 10% | FY2025 10-K |
A US company has to name every customer behind 10% or more of its revenue in its annual report. This page lists the listed companies whose latest 10-K, 20-F or 40-F names Cardinal Health that way. Suppliers below the 10% line, private suppliers and suppliers that keep the customer anonymous do not appear. Who depends on whom has the same disclosures across every company.